NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

I found this comment by GZ from the email 10Baggerz received very interesting:

Last week I was in San Diego for AACR annual meeting networking and meeting with people who will be able to collaborate with us and who are our supporters.

The way it is written (people who will be able to collaborate with us....) sounds like he's talking about "done deals"...like maybe he's putting the final touches on contracts (plural). It's a very awkward way to write something....unless you're trying to tell people something you can't tell them.

Just saying...crossing t's and dotting i's before the signatures make it final?
Right before, or at, approval??

Of course, I could be reading too much into it.

I'd love to see approval come tomorrow, but we're now in the zone where the new MHRA regs are live, so there's no concern that our trial jumped the gun (even though we believe that date was the beginning of April).

As for full approval vs. conditional approval, we really need full approval on GBM, otherwise the shorts have ammunition to disparage buyers and generally confuse investors. I suggest that GZ's comment on this issue may have something to do with giving conditional approvals to other possibilities such as DCVax-L plus poly ICLC, or Grade 3 GBM, or DCVax-L WITHOUT SOC radiation and chemo. I think they have so much evidence that DCVax-L works without Chemo/rad that they may need to approve it conditionally if they want DCVax-L/polyICLC to be the new standard of care. The UK is all about saving money on drugs that don't work, and may even be harmful, I can see this happening.

P.S: Thanks to another poster who offered the idea of these conditional approvals on this board a few days/weeks ago.